Julien Branchereau

Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population

Y. Neuzillet, X. Tillou, Romain Mathiéu et al. · European Urology · 2011 · 99 citations

Medicine, Oncology, Pathology +11

First World Consensus Conference on pancreas transplantation: Part II – recommendations

Ugo Boggi, Fabio Vistoli, Axel Andrès et al. · American Journal of Transplantation · 2021 · 92 citations · Full text

Medicine, Surgery, Dialysis +15

FR104, an Antagonist Anti-CD28 Monovalent Fab’ Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal Allograft

Nicolas Poirier, Nahzli Dilek, Caroline Mary et al. · American Journal of Transplantation · 2014 · 86 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection

Simon Ville, Nicolas Poirier, Julien Branchereau et al. · Journal of the American Society of Nephrology · 2016 · 58 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Marc Gigante, Y. Neuzillet, Jean‐Jacques Patard et al. · British Journal of Urology · 2012 · 56 citations

Medicine, Nephrology, Urology +17